Immunophenotypic and cytogenetic features of childhood acute leukemia in Serbia and Montenegro

Korean Journal of Genetics

Volumn 29, Issue 1, 2007, Pages 99-106

  Slavkovic, Bojana ^a   Guc Scekic, Marija ^a   Djuricic, Slavisa ^a   Janic, Dragana ^b   Gaipa, Giusepe ^c   Jankovic, Momcilo ^d   Krstic, Aleksandra ^a   Tasic, Zoran ^b   Micic, Dragan ^a   Bunjevacki, Gordana ^a  

^a Mother and Child Health Institute of Serbia Dr Vukan Cupic

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^c SAN GERARDO HOSPITAL   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Acute leukemia; Childhood; Cytogenetics; Immunophenotype; Low income countries

Indexed keywords

EID: 34247228672     PISSN: 02545934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui CH, Masera G, Conter V, Riehm H, Heerema N, Sallan S, Pullen J, Shuster J, Carroll A, Raimondi S and Richards S (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N. Engl. J. Med. 342: 998-1006.
2. Batinic D, Boranic M, Tiefenbach A, Rajic L, Femenic-Kes R and Konja J (1988) Subsets of childhood acute lymphoblastic leukemia in Croatia. Biomed. Pharmacother. 42: 133-134.
3. Benett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C (1976) French-American-British (FAB) Cooperative Group. Proposal for the classification of the acute leukemias. Br. J. Haematol. 33: 451-458.
4. Brunning RD, Matutes E and Flandrin G (2001) Acute myeloid leukaemia with recurrent genetic abnormalities. In: Jaffe ES, Harris ML, Stein H, and Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 81-87 pp.
5. Caligiuri MA, Strout MP and Gilliland DG (1997) Molecular biology of acute myeloid leukemia. Semin. Oncol. 24: 32-44.
6. Cline MJ (1994) The molecular basis of leukemia. N. Engl. J. Med. 330: 328-336.
7. Coebergh JWW, van der Does-van den Berg A, van Weiring ER, van Steensel-Moll HA, Valkenburg HA, van 't Veer MB, Schmitz PIM and van Zanen GE (1989) Childhood leukemia in The Netherlands, 1973-1986: Temporary variation of the incidence of acute lymphocytic leukemia in young children. Br. J. Cancer 59: 100-105.
8. Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman-Parker J, Perel Y, Michel G, Cornu G, Bordigoni P, Sommelet D, Leverger G, Hill C and Schaison G (1998) Critical study of prognostic factors in childhood acute lymphoblastic leukemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukemia Study Group. Br. J. Hematol. 102: 729-739.
9. Erber WN and Mason DY (1985) Immuno-alkaline phosphatase labeling of haematological samples: technique and applications. Leuk. Res. 9: 829-830.
10. Erber WN, Mynheer LC and Mason DY (1986) APAAP labeling of blood and bone marrow samples for phenotyping leukaemia. Lancet 5: 761-765.
11. Forestier E, Johansson B, Gustafsson G, Borgstrom G, Kerndrup G, Johannsson J and Heim S (2000) Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukemia: a Nordic series comparing two treatment periods. For the Nordic Society of Pediatric Hematology and Oncology (NOPHO) Leukemia cztogenetic study. Br. J. Haematol. 110: 147-153.
12. Garand R, Bene MC and the GEIL (1994) A new approach of acute lymphoblastic leukemia immunophewnotypic classification: 1984-1994 The GEIL expirience. Leukemia Lymphoma 13: 1-5.
13. Greaves MF, Colman SM, Beard MEJ, Bradstock K, Cabrera ME, Jacobs P, Lam-Po-Tang PRL, Mac-Dougall LG, Williams CKO and Alexander FE (1993) Geographical distribution of acute lymphoblastic leukemia subtypes: second report of the Collaborative Group Study. Leukemia 1: 27-34.
14. Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B and Richards S (2001) Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br. J. Haematol. 113: 103-114.
15. Kamel AM, Ghaleb FM, Assem MM, Hindawy DS, Jaffe ES and Magrath IT (1990) Phenotypic analysis of T-cell acute lymphoblastyc leukemia in Egypt. Leuk. Res. 14: 601-609.
16. Khalil SH, Quari MH, Jackson, JM, Pyle RH, el-Solh H and al-Nasser A (1994) Immunophenotyping of childhood acute lymphoblastic leukemia in Saudi Arabia: second look. Leukem Res 18: 881-883.
17. Kita K, Nishikori M and Uchino H (1985) Epidemiologic and immunologic characteristics of ALL and adult ATL in Japan. Leuk Res. 9: 781-787.
18. Ma SK, Wan TS and Chan LC (1999) Cytogenetics and molecular genetics of childhood leukemia. Hematol. Oncol. 17: 91-105.
19. Malta A, Baez F, Floresa A, Ocampo E, Pacheco C, Biondi A, Cantu-Rajnoldi A, Conter V, Gaipa G, Riva L, Sala A and Masera G (1997) Childhood acute lymphoblastic leukemia. Features at the onset in patients in Monza (Italy) and Managua (Nicaragua). Int. J. Pediatr. Hematol. Oncol. 4: 121-125.
20. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ and Estey E (1995) Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9: 965-971.
21. Mcnally RJQ and Parker L (2006) Environmental factors and childhood acute leukemias and lymphomas. Leuk Lymph. 47: 583-598.
22. Miller RW, Young JL Jr and Novakovic B (1994) Childhood cancer. Cancer 75: 395-405.
23. Mitelman F (1995) An International System for Human Cytogenetic nomenclature (ISCN 1995). Basel: S. Krager.
24. Mrozek K, Heinonen K, de la Chapelle A and Bloomfield CD (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Semin. Oncol. 24: 17-31.
25. Papamichail M, Megalakaki C, Cosmidou H and Maniatis H (1985) Epidemiology and immunological phenotype of childhood ALL in Greece. Leuk Res. 9: 773-775.
26. Parkin DM, Stiller CA, Draper GJ and Bieber CA (1998) The international incidence of childhood cancer. Int. J. Cancer 42: 511-520.
27. Pombo-de-Oliveira MS, Cordoba JC, Alencar DM, Campos MM, Carrico K, Dobbin J, Dorea MD, Ferreira R, Mendonca N and Magalhaes IQ (2005) Biological diversity variations of pediatric acute leukemia in Brazil: contribution og immunophenotypic profiles to epidemiological studies. Rev. Bras. Hematol. Hemoter. 27: 21-26.
28. Pui CH (1999) Childhood leukemias. Cambridge: University Press.
29. Pui CH, Behm FG and Crist WM (1993) Clinical and biological relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82: 343-362.
30. Pui CH and Evans WE (1998) Acute lymphoblastic leukemia. N. Engl. J. Med. 339:605-615.
31. Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG and Pui CH (2003) Reassessment of the prognostic significance of hypodyploidy in pediatric patients with acute lymphoblastic leukemia. Cancer 98: 2715-2722.
32. Ramot B and Magrath I (1982) Hypothesis: the environment is a major determinant of the immunological subtype of lymphoma and acute lymphoblastic leukemia in children. Br. J. Haematol. 52: 183-189.
33. Ribeiro RC, Broniscer A, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Crist W, Evans WE and Pui CH (1997) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts Leukemia. Leukemia 11: 1493-1496.
34. Russo F (1985) Childhood T-cell acute lymphoblastic leukaemia in the Campania region in Italy 1980-1984. Leuk Res. 9: 771-772.
35. Taskov H, Dimitrova E, Serbinova M, Mendisova L and Bobev D (1995) Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria. Leuk Res. 19: 877-881.
36. Van den Does-van den Berg A, Bartram CR, Basso G, Benoit YCM, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U, Lampert F, Wolf-Dieter L, Niemeyer CM and Wering ER (1992) Minimal requirements for diagnosis, classification and evaluation of the treatement of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med. Pediatr. Oncol. 20: 497-505.